The histologic spectrum of the astrocytomas that arise as part of this syndrome is not well described, nor are the additional genetic alterations that drive these astrocytomas apart from the germline CDKN2A inactivation. This evidence concerns the gene CDKN2A and astrocytoma (excluding glioblastoma).